# The Purpose of the Study is to Gain an In-depth Picture of the Patient Management and Prescription Behaviours

> **NCT01377896** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 221 (actual)

## Conditions studied

- Schizophrenia
- Bipolar Disorders
- Major Depressive Disorders

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01377896
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 221 (ACTUAL)
- **Last updated:** 2011-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01377896

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01377896, "The Purpose of the Study is to Gain an In-depth Picture of the Patient Management and Prescription Behaviours". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01377896. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*